内分泌代謝高血圧研究部
発表論文
2022年
- Kitamura T, Blinder AR, Nanba K, Tsuiki M, Mishina M, Okuno H, Moriyoshi K, Yamazaki Y, Sasano H, Yoneyama K, Udager AM, Rainey WE, Yasoda A, Satoh-Asahara N, Tagami T. ACTH-independent production of 11-oxygenated androgens and glucocorticoids in an adrenocortical adenoma. Eur J Endocrinol, 187: K39-K45, 2022.
- Komiyama M, Ozaki Y, Wada H, Yamakage H, Satoh-Asahara N, Yasoda A, Sunagawa Y, Morimoto T, Tamaki S, Suzuki M, Shibayama T, Kato T, Okada Y, Kita T, Takahashi Y. Randomized double-blind placebo-controlled multicenter trial for the effects of a polyherbal remedy, Yokukansan(YiganSan), in smokers with depressive tendencies. BMC Complement Med Ther, 22: 311, 2022.
- Satoh-Asahara N,Yamakage H, Tanaka T, Kawasaki T, Matsuura S, Tatebe H, Akiguchi I, Tokuda T. Soluble TREM2 and Alzheimer-related biomarker trajectories in the blood of patients with diabetes based on their cognitive status. Diabetes Res Clin Pract, 193:110121, 2022.
- ISCHIA Study Group. Prevention of hypoglycemia by intermittent-scanning continuous glucose monitoring device combined with structured education in patients with type 1 diabetes mellitus: A randomized, crossover trial. Diabetes Res Clin Pract, 195: 110147, doi:10.1016/j.diabres.2022.110147., Online ahead of print, 2022.
- Kawai S, Yamakage H, Kotani K, Noda M, Satoh-Asahara N, Hashimoto K. Analysis of time-dependent changes in the FIB4 index in obese patients receiving weight reduction therapy. Sci Rep. 12:15219, 2022.
- Komiyama M, Ozaki Y, Wada H, Yamakage H, Satoh-Asahara N, Kishimoto A, Katsuura Y, Imaizumi A, Hashimoto T, Sunagawa Y, Morimoto T, Hasegawa K. Study protocol to determination of the effects of highly absorbable oral curcumin on the indicators of cognitive functioning: A double-blind randomized controlled trial. BMJ Open, 12:e057936, 2022.
- Funamoto M, Sunagawa Y, Ktanasaka Y, Kato T, Funada J, Ajiro Y, Komiyama M, Akao M, Yasoda A, Yamakage H, Satoh-Asahara N, Wada H, Ikeda Y, Morimoto T, Hasegawa K. Effects of High-Absorption Curcumin for the Prevention of Hypertensive Heart Disease: A Double-blind, Placebo-controlled, Randomised Clinical Study. Eur Heart J Open. 2:oeac057, 2022
- Suzuki K, Tsujiguchi H, Hara A, Nakamura H, Kotani K, Noda M, Yamakage H, Satoh-Asahara N, Takamura T. Cystatin C-based eGFR predicts cardiovascular disease in patients with overweight/obesity and hyperglycemia. Obes Sci Pract. 9:4-14, 2022
- Hata A, Komiyama M, Yasoda A, Wada H, Yamakage H, Satoh-Asahara N, Morimoto T, Takahashi Y, Hasegawa K. Psychological Effects of Aromatherapy on Smokers With Depressive Tendencies During Smoking Cessation Treatment: Protocol for a Pre-Post Single-Arm Clinical Trial. JMIR Res Protoc. 11: e38626, 2022
- Tanaka M, Yamakage H, Muranaka K, Yamada T, Araki R, Ogo A, Matoba M, Watanabe T, Saito M, Kurita S, Yonezawa K, Tanaka T, Suzuki M, Sawamura M, Matsumoto M, Nishimura M, Kusakabe T, Wada H, Hasegawa K, Kotani K, Noda M, Satoh-Asahara N (corresponding). Higher serum soluble TREM2 as a potential indicative biomarker for cognitive impairment in inadequately controlled type 2 diabetes without obesity: the DOR-KyotoJ-1.Front Endocrinol. 13: 880148, doi: 10.3389/fendo.2022.880148., 2022 (IF: 5.555, CI: none) 査読付
- Ikeue K, Kusakabe T, Muranaka K, Yamakage H, Inoue T, Ishii K, Satoh-Asahara N. A combined index of waist circumference and muscle quality is associated with cardiovascular disease risk factor accumulation in Japanese obese patients: A cross-sectional study. Endocrine. 77:30-40, 2022 (IF: 3.633, CI: none) 査読付
- Furuto-Kato S, Araki A, Chiba Y, Nakamura M, Shintani M, Kuwahara T, Yamakage H, Satoh-Asahara N, Tagami T. Relationship between the thyroid function and cognitive impairment in the elderly in Japan. Intern Med. 61: 3029-3036, 2022 (IF: 1.271, CI: none) 査読付
- Wada H, Shinozaki T, Suzuki M, Sakagami S, Ajiro Y, Funada J, Matsuda M, Shimizu M, Takenaka T, Morita Y, Yonezawa K, Matsubara H, Ono Y, Nakamura T, Fujimoto K, Ninomiya A, Kato T, Unoki T, Takagi D, Wada K, Wada M, Iguchi M, Yamakage H, Kusakabe T, Yasoda A, Shimatsu A, Kotani K, Satoh-Asahara N, Abe M, Akao M, Hasegawa K. Impact of chronic kidney disease on the associations of cardiovascular biomarkers with adverse outcomes in patients with suspected or known coronary artery disease: The EXCEED-J study. J Am Heart Assoc. 11: e023464, 2022 (IF: 5.501, CI: 0) 査読付
- Wada M, Yakaguchi K, Yamakage H, Inoue T, Kusakabe T, Abiko K, Takakura K, Konishi I, Satoh-Asahara N. Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer. Int J Clin Oncol. 27: 434-440, 2022 (IF: 3.402, CI: 0) 査読付
- Akamatsu Y, Kusakabe T, Arai H, Yamamoto Y, Nakao K, Ikeue K, Ishihara Y, Tagami T, Yasoda A, Ishii K, Satoh-Asahara N. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. J Cachexia Sarcopenia Muscle. 13: 180-189, 2022 (IF: 12.910, CI: 0) 査読付
- Ohara T, Hata J, Tanaka M, Honda T, Yamakage H, M.Eng., Inoue T, Hirakawa Y, Kusakabe T, Shibata M, Kitazono T, Nakao T, Satoh-Asahara N, Ninomiya T. Association of daily sleep duration with the incident dementia by serum soluble TREM2 in a community. J Am Geriatr Soc. 70: 1147-1156, 2022 (IF: 5.562, CI: 0) 査読付
- Mittal S, Komiyama M, Ozaki Y, Yamakage H, Satoh-Asahara N, Yasoda A, Wada H, Funamoto M, Shimizu K, Miyazaki Y, Katanasaka Y, Sunagawa Y, Morimoto T, Takahashi Y, Nakayama T, Hasegawa K. Gingival bleeding and pocket depth among smokers and the related changes after short-term smoking cessation. Acta Odontol Scand. 80: 258-263, 2022 (IF: 2.331, CI: 0) 査読付
- Ishihara Y, Umakoshi H, Kaneko H, Nanba K, Tsuiki M, Kusakabe T, Satoh-Asahara N, Yasoda A, Tagami T. Prediction of long-term biochemical cure in patients with unilateral primary hyperaldosteronism treated surgically based on the early post-operative plasma aldosterone value. Endocr J. 69: 407-415, 2022 (IF: 2.349, CI: 0) 査読付